Additionally, identification of FGFR3 alteration site further revealed that p.Arg248Cys (0.00% vs. 10.64%, p < 0.05, Supplementary Figure 5) was less prevalent in early-stage UCB when compared with early-stage UTUC. Here, FGFR3 is linked to renal pelvis/ureter urothelial carcinoma.